On January 22, 2021, Mr. Zuo Ding, Deputy Secretary of the Party Committee and President of Shenzhen Capital Group Co., Ltd., and Mr. Shao Gang, Deputy Secretary of the Party Committee, visited Shenzhen Sciencare medical industries Co., Ltd. to inspect and guide the work.

When guiding the work, Sciencare Medical’s chairman Mr. Yin Shugui, executive deputy general manager and director Zhang Tao and all the company’s senior executives and the leaders of Shenzhen Capital Group Co., Ltd. had a discussion. Both parties mainly discussed the current status of business operations, industry development, and business development needs. In-depth exchanges were conducted.

Deputy Secretary of Party Committee, President Mr. Zuo Ding (left) Deputy Secretary of Party Committee Mr. Shao Gang (right)

At the forum between the two parties, Mr. Yin Shugui, Chairman of Sciencare Medical, introduced the company's recent business status and future development plans from multiple perspectives such as the development of the industry and drug research and development.

As strategic investors of Sciencare Medical, the two leaders of Shenzhen Capital Group Co., Ltd. fully affirmed the development prospects of drug treatment and the company's development after in-depth understanding, and expressed that they would increase support for Sciencare Medical and make Sciencare Medical a family Companies that contribute to society.

As a well-known investment banking expert in the industry, Mr. Zuo Ding is full of confidence in the development prospects of our company. After the meeting, he highly praised the current achievements of Sciencare Medical in drug research and development, and said that he was "encouraged".

With the support and affirmation of the leaders of Shenzhen Capital Group Co., Ltd.， Sciencare Medical will also accumulate strength and firm beliefs, create more value in the field of addiction treatment, welcome the bright sunrise of tomorrow as a strong person, and inject more power into the company’s thriving development. The driving force of the company, to contribute its own meager power to a healthy China.

The investigation and guidance ended in a happy atmosphere. We believe that under the support and guidance of the leaders of Shenzhen Capital Group co.,ltd, the future road of Sciencare Medical will be more brilliant!

About Shenzhen Capital Group Co., Ltd.

Shenzhen Capital Group Co., Ltd. was established in 1999 by the Shenzhen Municipal Government and guided by social capital. The registered capital is 5.42 billion yuan, and the total scale of various funds under management is about 35.137 billion yuan.

Relying on its outstanding performance in the field of venture capital,Shenzhen Capital Group Co., Ltd. has been ranked among the top in the comprehensive ranking of venture capital institutions organized by authoritative institutions such as China Venture Capital Committee, Zero2IPO Group, and China Investment Group. In 2019, in the annual selection of Zero2IPO's "Top 50 Venture Capital Institutions in China", Shenzhen Capital Group Co., Ltd. won the second place in the comprehensive ranking of domestic and foreign venture capital institutions (the first place in local venture capital institutions).